Dr. Dempsey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3200 Tower Oaks Blvd
Suite 250
Rockville, MD 20852Phone+1 301-770-7373Fax+1 301-770-7272- Is this information wrong?
Education & Training
- Joslin Diabetes CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1989
- Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1988
- George Washington UniversityResidency, Internal Medicine, 1984 - 1986
- George Washington UniversityInternship, Internal Medicine, 1983 - 1984
- Harvard Medical SchoolClass of 1983
Certifications & Licensure
- MD State Medical License 1986 - 2024
- DC State Medical License 1985 - 1986
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Compassionate Doctor Award Vitals American Registry, 2011, 2016, 2018-2021
- Top Doctors Endocrinology and Metabolism Castle Connolly, 2009-2021
- Top Doctors Washingtonian Magazine, 2009-2021
- Join now to see all
Clinical Trials
- Sitagliptin Cardiovascular Outcomes Study (MK-0431-082) Start of enrollment: 2008 Dec 10
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) Start of enrollment: 2010 Jun 01
- EXCEL Clinical Trial Start of enrollment: 2010 Sep 29
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsIdeglira is Associated With Improved Short-Term Clinical Outcomes and Cost Savings Compared with Insulin Glargine U100 Plus Insulin Aspart in the U.S.Michael Dempsey, Michelle Mocarski, Jakob Langer, Barnaby Hunt> ;Endocrine Practice. 2018 Oct 11
- 3 citationsLong-term cost-effectiveness analysis shows that IDegLira is associated with improved outcomes and lower costs compared with insulin glargine U100 plus insulin aspart ...Michael Dempsey, Michelle Mocarski, Jakob Langer, Barnaby Hunt> ;Journal of Medical Economics. 2018 Sep 6
Committees
- Member, AACE Public Impact Committee 2018 - Present
- Board Member, Mid-Atlantic Regional Chapter AACE 2011 - Present
- President, Mid-Atlantic Regional Chapter AACE 2018 - 2020
- Committee member, AACE Underserved Population Committee 2016 - 2018
- Vice-President, Mid-Atlantic Regional Chapter AACE 2016 - 2018
- Committee Member, Institutional Review Board, Washington Adventist Health Care 2012 - 2017
- Committee member, AACE Clinical Research Committee 2012 - 2015
- Steering Committee, Healthy Montgomery 2011 - 2012
- Chair, Community Outreach Committee, Montgomery County Medical Society 2011 - 2012
- Board Member, Montgomery County Medical Society 2011 - 2012
- Associate Editor, Montgomery Medicine 1999 - 2000
- Assistant Editor, Montgomery Medicine 1998 - 1999
Research History
- Clinical TrialsOver 150 Phase 2 and Phase 3 clinical trials as PI or sub-I since 1988. Research interests include diabetes, lipid disorders, CV disease and male hypogonadism. Please contact office for a copy of my full research CV.1998 - Present
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Hospital Affiliations
- Adventist Healthcare Shady Grove Medical CenterRockville, Maryland
External Links
- my websitehttp://www.thediabetesdoc.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: